Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (14555)
All Articles published online
|
Aug 7, 2010 (publication date) through Apr 15, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Blonski W, Kotlyar DS, Forde KA. Non-viral causes of hepatocellular carcinoma. World J Gastroenterol 2010; 16(29): 3603-3615 [PMID: 20677332 DOI: 10.3748/wjg.v16.i29.3603] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i29/3603.htm |
| Number | Citing Articles |
| 1 |
Beicheng Sun, Michael Karin. Obesity, inflammation, and liver cancer. Journal of Hepatology 2012; 56(3): 704 doi: 10.1016/j.jhep.2011.09.020
|
| 2 |
Fuminori Sonohara, Suguru Yamada, Nobutake Tanaka, Mitsuru Tashiro, Yuki Sunagawa, Daishi Morimoto, Haruyoshi Tanaka, Hideki Takami, Masamichi Hayashi, Mitsuro Kanda, Chie Tanaka, Daisuke Kobayashi, Goro Nakayama, Masahiko Koike, Michitaka Fujiwara, Yasuhiro Kodera. Comparison of non‐invasive liver reserve and fibrosis models: Implications for surgery and prognosis for hepatocellular carcinoma. Hepatology Research 2019; 49(11): 1305 doi: 10.1111/hepr.13400
|
| 3 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 2961 doi: 10.1007/978-3-319-26956-6_165
|
| 4 |
Adviti Naik, Rok Košir, Damjana Rozman. Genomic aspects of NAFLD pathogenesis. Genomics 2013; 102(2): 84 doi: 10.1016/j.ygeno.2013.03.007
|
| 5 |
|
| 6 |
Fadi Antaki, Stephanie Judd, Ziad Kanaan, Suhag M. Patel, Kirthi K. Lilley. Textbook of Gastrointestinal Oncology. 2019; : 573 doi: 10.1007/978-3-030-18890-0_32
|
| 7 |
Wei-Shan Chin, Shin-Chun Pan, Ching-Chun Huang, Pei-Jer Chen, Yue Leon Guo. Exposure to Air Pollution and Survival in Follow-Up after Hepatocellular Carcinoma. Liver Cancer 2022; 11(5): 474 doi: 10.1159/000525346
|
| 8 |
Yasuna Kobayashi, Mayumi Toda, Takeshi Aoki, Masahiko Murakami, Toshinori Yamamoto. Genotyping of coding single nucleotide variants of the hOAT2[SLC22A7] gene in Japanese patients with non-viral liver tumor. Gene Reports 2016; 5: 102 doi: 10.1016/j.genrep.2016.09.006
|
| 9 |
Ling‐yuan Zeng, Shu‐yan Yang, Zhi‐qiang Zhang, Tao Wang, Yu‐ze Wang, Xiao‐chun Wei. Effect of Cholecystectomy on the Occurrence of Knee Osteoarthritis. Orthopaedic Surgery 2020; 12(3): 756 doi: 10.1111/os.12671
|
| 10 |
O. Rosmorduc, L. Fartoux. HCC and NASH: How strong is the clinical demonstration?. Clinics and Research in Hepatology and Gastroenterology 2012; 36(3): 202 doi: 10.1016/j.clinre.2011.12.011
|
| 11 |
Sui-Whi Jane, Ming-Shyan Lin, Wen-Nan Chiu, Li-Ju Lai, Po-Han Chen, Mei-Yen Chen. Early detection of unhealthy behaviors, the prevalence and receipt of antiviral treatment for disabled adult hepatitis B and C carriers. BMC Public Health 2016; 16(1) doi: 10.1186/s12889-016-2844-0
|
| 12 |
Olga Pivovarova, Annika Höhn, Tilman Grune, Andreas F.H. Pfeiffer, Natalia Rudovich. Insulin-degrading enzyme: new therapeutic target for diabetes and Alzheimer’s disease?. Annals of Medicine 2016; 48(8): 614 doi: 10.1080/07853890.2016.1197416
|
| 13 |
Reem Ezzat, Mohamed Eltabbakh, Mohamed El Kassas. Unique situation of hepatocellular carcinoma in Egypt: A review of epidemiology and control measures. World Journal of Gastrointestinal Oncology 2021; 13(12): 1919-1938 doi: 10.4251/wjgo.v13.i12.1919
|
| 14 |
Kathrine S Rallis, Dimitrios Makrakis, Ioannis A Ziogas, Georgios Tsoulfas. Immunotherapy for advanced hepatocellular carcinoma: From clinical trials to real-world data and future advances. World Journal of Clinical Oncology 2022; 13(6): 448-472 doi: 10.5306/wjco.v13.i6.448
|
| 15 |
Ram C. Shankaraiah, Laura Gramantieri, Francesca Fornari, Silvia Sabbioni, Elisa Callegari, Massimo Negrini. Animal Models of Hepatocellular Carcinoma Prevention. Cancers 2019; 11(11): 1792 doi: 10.3390/cancers11111792
|
| 16 |
Tao Wang, Junjie Kong, Xianwei Yang, Shu Shen, Menglan Zhang, Wentao Wang. Clinical features of sarcomatoid change in patients with intrahepatic cholangiocarcinoma and prognosis after surgical liver resection: A Propensity Score Matching analysis. Journal of Surgical Oncology 2020; 121(3): 524 doi: 10.1002/jso.25815
|
| 17 |
Chia-Hung Lin, Ching-Yao Chang, Kuan-Rong Lee, Hui-Ju Lin, Wu-Chou Lin, Ter-Hsin Chen, Lei Wan. Cold-water extracts of Grifola frondosa and its purified active fraction inhibit hepatocellular carcinoma in vitro and in vivo. Experimental Biology and Medicine 2016; 241(13): 1374 doi: 10.1177/1535370216640149
|
| 18 |
Badr Alzahrani, Tristan J. Iseli, Lionel W. Hebbard. Non-viral causes of liver cancer: Does obesity led inflammation play a role?. Cancer Letters 2014; 345(2): 223 doi: 10.1016/j.canlet.2013.08.036
|
| 19 |
Xiao-Feng Duan, Peng Tang, Qiang Li, Zhen-Tao Yu. Obesity, adipokines and hepatocellular carcinoma. International Journal of Cancer 2013; 133(8): 1776 doi: 10.1002/ijc.28105
|
| 20 |
Iris Suarez M., Diego Uribe, Carlos M. Jaramillo, German Osorio, Juan C. Perez, Rocio Lopez, Sergio Hoyos, Pierre Hainaut, Pascal Pineau, Maria-C. Navas. Wnt/β-catenin signaling pathway in hepatocellular carcinomas cases from Colombia. Annals of Hepatology 2015; 14(1): 64 doi: 10.1016/S1665-2681(19)30802-6
|
| 21 |
Maryanne C.S. Herzig, Kim Hildreth, Jessica Huamani, Marissa Perez, Beth A. Goins, C. Alex McMahan, Robert L. Reddick, Christi A. Walter. Human O6‐methylguanine‐DNA methyltransferase containing C145A does not prevent hepatocellular carcinoma in C3HeB/FeJ transgenic mice. Molecular Carcinogenesis 2013; 52(4): 275 doi: 10.1002/mc.21855
|
| 22 |
Sema Tuna Torunoglu, Agnieszka Zajda, Janne Tampio, Magdalena Markowicz-Piasecka, Kristiina M. Huttunen. Metformin derivatives – Researchers’ friends or foes?. Biochemical Pharmacology 2023; 215: 115743 doi: 10.1016/j.bcp.2023.115743
|
| 23 |
Awang Danzeng, Ling Guo, Zhen-hua Yang, Zheng-wei He, Cheng-long Zeng, Pingcuo Ciren, Run-hu Lan, Xue-wei Jiang, Chao Wang, Bin-hao Zhang. Postoperative lenvatinib + PD-1 blockade reduces early tumor recurrence in hepatocellular carcinoma with microvascular invasion (Barcelona Clinic Liver Cancer stage 0 or A): a propensity score matching analysis. Journal of Gastrointestinal Surgery 2024; 28(7): 1104 doi: 10.1016/j.gassur.2024.05.001
|
| 24 |
Al B. Benson, Michael I. D’Angelica, Daniel E. Abbott, Thomas A. Abrams, Steven R. Alberts, Daniel A. Anaya, Robert Anders, Chandrakanth Are, Daniel Brown, Daniel T. Chang, Jordan Cloyd, Anne M. Covey, William Hawkins, Renuka Iyer, Rojymon Jacob, Andreas Karachristos, R. Kate Kelley, Robin Kim, Manisha Palta, James O. Park, Vaibhav Sahai, Tracey Schefter, Jason K. Sicklick, Gagandeep Singh, Davendra Sohal, Stacey Stein, G. Gary Tian, Jean-Nicolas Vauthey, Alan P. Venook, Lydia J. Hammond, Susan D. Darlow. Guidelines Insights: Hepatobiliary Cancers, Version 2.2019. Journal of the National Comprehensive Cancer Network 2019; 17(4): 302 doi: 10.6004/jnccn.2019.0019
|
| 25 |
Lina Elsalem, Ahmad A Jum'ah, Mahmoud A Alfaqih, Osama Aloudat. <p>The Bacterial Microbiota of Gastrointestinal Cancers: Role in Cancer Pathogenesis and Therapeutic Perspectives</p>. Clinical and Experimental Gastroenterology 2020; : 151 doi: 10.2147/CEG.S243337
|
| 26 |
Masato Fujii, Yuichiro Shibazaki, Kyoko Wakamatsu, Yutaka Honda, Yusuke Kawauchi, Kenji Suzuki, Somasundaram Arumugam, Kenichi Watanabe, Takafumi Ichida, Hitoshi Asakura, Hiroyuki Yoneyama. A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma. Medical Molecular Morphology 2013; 46(3): 141 doi: 10.1007/s00795-013-0016-1
|
| 27 |
Xiao-Yan Duan, Liang Qiao, Jian-Gao Fan. Clinical features of nonalcoholic fatty liver disease-associated hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International 2012; 11(1): 18 doi: 10.1016/S1499-3872(11)60120-3
|
| 28 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_165-1
|
| 29 |
Mayara Lilian Paulino Miranda, Kelly Silva Furtado, Fábia de Oliveira Andrade, Renato Heidor, Raquel Santana da Cruz, Marina Sayuri Nogueira, Inar Alves de Castro, Eduardo Purgatto, Luis Fernando Barbisan, Fernando Salvador Moreno. β-ionone inhibits nonalcoholic fatty liver disease and its association with hepatocarcinogenesis in male Wistar rats. Chemico-Biological Interactions 2019; 308: 377 doi: 10.1016/j.cbi.2019.05.046
|
| 30 |
Manal A Hamed, Sanaa A Ali. Non-viral factors contributing to hepatocellular carcinoma. World Journal of Hepatology 2013; 5(6): 311-322 doi: 10.4254/wjh.v5.i6.311
|
| 31 |
Natsumi Maehara, Satoko Arai, Mayumi Mori, Yoshihiro Iwamura, Jun Kurokawa, Toshihiro Kai, Shunsuke Kusunoki, Kaori Taniguchi, Kazutaka Ikeda, Osamu Ohara, Ken-ichi Yamamura, Toru Miyazaki. Circulating AIM Prevents Hepatocellular Carcinoma through Complement Activation. Cell Reports 2014; 9(1): 61 doi: 10.1016/j.celrep.2014.08.058
|
| 32 |
Hamid Ceylan. Identification of hub genes associated with obesity-induced hepatocellular carcinoma risk based on integrated bioinformatics analysis. Medical Oncology 2021; 38(6) doi: 10.1007/s12032-021-01510-0
|
| 33 |
Shigekazu Ukawa, Akiko Tamakoshi, Kenji Wakai, Youichi Kurozawa. Associations of daily walking and television viewing time with liver cancer mortality: findings from the Japan Collaborative Cohort Study. Cancer Causes & Control 2014; 25(7): 787 doi: 10.1007/s10552-014-0380-8
|
| 34 |
Hala Elnakat Thomas, Carol A. Mercer, Larissa S. Carnevalli, Jongsun Park, Jesper B. Andersen, Elizabeth A. Conner, Kazuhiro Tanaka, Tomoo Matsutani, Akio Iwanami, Bruce J. Aronow, Liu Manway, S. Michel Maira, Snorri S. Thorgeirsson, Paul S. Mischel, George Thomas, Sara C. Kozma. mTOR Inhibitors Synergize on Regression, Reversal of Gene Expression, and Autophagy in Hepatocellular Carcinoma. Science Translational Medicine 2012; 4(139) doi: 10.1126/scitranslmed.3003923
|
| 35 |
|
| 36 |
Irina G. Minko, Plamen P. Christov, Liang Li, Michael P. Stone, Amanda K. McCullough, R. Stephen Lloyd. Processing of N-substituted formamidopyrimidine DNA adducts by DNA glycosylases NEIL1 and NEIL3. DNA Repair 2019; 73: 49 doi: 10.1016/j.dnarep.2018.11.001
|
| 37 |
Martin C. S. Wong, Johnny Y. Jiang, William B Goggins, Miaoyin Liang, Yuan Fang, Franklin D. H. Fung, Colette Leung, Harry H. X. Wang, Grace L. H. Wong, Vincent W.S. Wong, Henry L. Y. Chan. International incidence and mortality trends of liver cancer: a global profile. Scientific Reports 2017; 7(1) doi: 10.1038/srep45846
|
| 38 |
Alain Braillon. Adding care to cure for patients with liver disease: A cultural shift. Hepatology 2018; 67(3): 1172 doi: 10.1002/hep.29608
|
| 39 |
Vaibhav Chand, Akshay Pandey, Dragana Kopanja, Grace Guzman, Pradip Raychaudhuri. Opposing Roles of the Forkhead Box Factors FoxM1 and FoxA2 in Liver Cancer. Molecular Cancer Research 2019; 17(5): 1063 doi: 10.1158/1541-7786.MCR-18-0968
|
| 40 |
Olivier Rosmorduc. Relationship between hepatocellular carcinoma, metabolic syndrome and non-alcoholic fatty liver disease: Which clinical arguments?. Annales d'Endocrinologie 2013; 74(2): 115 doi: 10.1016/j.ando.2013.02.008
|
| 41 |
Jie Li, Xu Han, Xiaona Yu, Zongzhen Xu, Guangsheng Yang, Bingqi Liu, Peng Xiu. Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA. Journal of Experimental & Clinical Cancer Research 2018; 37(1) doi: 10.1186/s13046-018-0893-1
|
| 42 |
Magdalena Stepien, Talita Duarte-Salles, Veronika Fedirko, Antonia Trichopoulou, Pagona Lagiou, Christina Bamia, Kim Overvad, Anne Tjønneland, Louise Hansen, Marie-Christine Boutron-Ruault, Guy Fagherazzi, Gianluca Severi, Tilman Kühn, Rudolf Kaaks, Krasimira Aleksandrova, Heiner Boeing, Eleni Klinaki, Domenico Palli, Sara Grioni, Salvatore Panico, Rosario Tumino, Alessio Naccarati, H. Bas Bueno-de-Mesquita, Petra H. Peeters, Guri Skeie, Elisabete Weiderpass, Christine L. Parr, José Ramón Quirós, Genevieve Buckland, Esther Molina-Montes, Pilar Amiano, Maria-Dolores Chirlaque, Eva Ardanaz, Emily Sonestedt, Ulrika Ericson, Maria Wennberg, Lena Maria Nilsson, Kay-Tee Khaw, Nick Wareham, Kathryn E. Bradbury, Heather A. Ward, Isabelle Romieu, Mazda Jenab. Consumption of soft drinks and juices and risk of liver and biliary tract cancers in a European cohort. European Journal of Nutrition 2016; 55(1): 7 doi: 10.1007/s00394-014-0818-5
|
| 43 |
Ans Jacobs, Anne‐Sophie Warda, Jef Verbeek, David Cassiman, Pieter Spincemaille. An Overview of Mouse Models of Nonalcoholic Steatohepatitis: From Past to Present. Current Protocols in Mouse Biology 2016; 6(2): 185 doi: 10.1002/cpmo.3
|
| 44 |
Giuseppe Tarantino, Paolo Magistri, Roberto Ballarin, Raffaele Di Francia, Massimiliano Berretta, Fabrizio Di Benedetto. Oncological Impact of M-Tor Inhibitor Immunosuppressive Therapy after Liver Transplantation for Hepatocellular Carcinoma: Review of the Literature. Frontiers in Pharmacology 2016; 7 doi: 10.3389/fphar.2016.00387
|
| 45 |
Alvina Munaf, Muhammad Sadik Memon, Prem Kumar, Sultan Ahmed, Maheshwari Bhunesh Kumar. Comparison of Viral Hepatitis-Associated Hepatocellular Carcinoma Due to HBV and HCV - Cohort from Liver Clinics in Pakistan. Asian Pacific Journal of Cancer Prevention 2014; 15(18): 7563 doi: 10.7314/APJCP.2014.15.18.7563
|
| 46 |
Anupam Bishayee, Roslin J. Thoppil, Altaf S. Darvesh, Vahagn Ohanyan, J. Gary Meszaros, Deepak Bhatia. Pomegranate phytoconstituents blunt the inflammatory cascade in a chemically induced rodent model of hepatocellular carcinogenesis. The Journal of Nutritional Biochemistry 2013; 24(1): 178 doi: 10.1016/j.jnutbio.2012.04.009
|
| 47 |
Pawel Jaruga, Rachana Tomar, Melis Kant, Vladimir Vartanian, Benjamin Sexton, Carmelo J. Rizzo, Robert J. Turesky, Michael P. Stone, R. Stephen Lloyd, Miral Dizdaroglu. Synthesis and Characterization of 15N5-Labeled Aflatoxin B1–Formamidopyrimidines and Aflatoxin B1–N7-Guanine from a Partial Double-Stranded Oligodeoxynucleotide as Internal Standards for Mass Spectrometric Measurements. ACS Omega 2023; 8(16): 14841 doi: 10.1021/acsomega.3c01328
|
| 48 |
Yun Yang, Tian Xia, Ning Li, Jin Zhang, Yuan Yang, Wenming Cong, Qiang Deng, Ke Lan, Weiping Zhou. Combined effects of p53 and MDM2 polymorphisms on susceptibility and surgical prognosis in hepatitis B virus-related hepatocellular carcinoma. Protein & Cell 2013; 4(1): 71 doi: 10.1007/s13238-012-2067-9
|
| 49 |
Shingo Yamada, Atsushi Kawaguchi, Takumi Kawaguchi, Nobuyoshi Fukushima, Ryoko Kuromatsu, Shuji Sumie, Akio Takata, Masahito Nakano, Manabu Satani, Tatsuyuki Tonan, Kiminori Fujimoto, Hiroji Shima, Tatsuyuki Kakuma, Takuji Torimura, Michael R. Charlton, Michio Sata. Serum albumin level is a notable profiling factor for non‐B, non‐C hepatitis virus‐related hepatocellular carcinoma: A data‐mining analysis. Hepatology Research 2014; 44(8): 837 doi: 10.1111/hepr.12192
|
| 50 |
Mayumi Toda, Yasuna Kobayashi, Tomotake Koizumi, Koji Saito, Masayuki Ohbayashi, Noriko Kohyama, Takeshi Aoki, Masahiko Murakami, Hajime Yasuhara, Toshinori Yamamoto. Genetic polymorphism of the human organic solute carrier protein 1 (hOSCP1) gene in Japanese patients with non-viral liver carcinoma. Meta Gene 2014; 2: 686 doi: 10.1016/j.mgene.2014.09.002
|
| 51 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_164-1
|
| 52 |
Emiliano Alberto Gentile, Cynthia Cecilia Castronuovo, María Luján Cuestas, Natalia Gómez, Carlos Davio, José Raúl Oubiña, Verónica Lidia Mathet. F127 poloxamer effect on cytotoxicity induction of tumour cell cultures treated with doxorubicin. Journal of Pharmacy and Pharmacology 2019; 71(11): 1655 doi: 10.1111/jphp.13158
|
| 53 |
Benoit Lacoste, Valérie-Ann Raymond, Shamir Cassim, Pascal Lapierre, Marc Bilodeau, Matias A Avila. Highly tumorigenic hepatocellular carcinoma cell line with cancer stem cell-like properties. PLOS ONE 2017; 12(2): e0171215 doi: 10.1371/journal.pone.0171215
|
| 54 |
X. Cai, Y. Gan, Y. Fan, J. Hu, Y. Jin, F. Chen, T. Chen, Y. Sun, J. Wang, W. Qin, Hong Tu. The adiponectin gene single-nucleotide polymorphism rs1501299 is associated with hepatocellular carcinoma risk. Clinical and Translational Oncology 2014; 16(2): 166 doi: 10.1007/s12094-013-1056-7
|
| 55 |
Patrícia Lofêgo Gonçalves, Maria da Penha Zago-Gomes, Carlos Sandoval Gonçalves, Fausto Edmundo Lima Pereira. Hepatitis virus and hepatocellular carcinoma in Brazil: a report from the State of Espírito Santo. Revista da Sociedade Brasileira de Medicina Tropical 2014; 47(5): 559 doi: 10.1590/0037-8682-0145-2014
|
| 56 |
Mark Farha, Neil K. Jairath, Theodore S. Lawrence, Issam El Naqa. Characterization of the Tumor Immune Microenvironment Identifies M0 Macrophage-Enriched Cluster as a Poor Prognostic Factor in Hepatocellular Carcinoma. JCO Clinical Cancer Informatics 2020; (4): 1002 doi: 10.1200/CCI.20.00077
|
| 57 |
Chin‐Hsiao Tseng. Diabetes is not an independent risk factor for hepatocellular carcinoma. Diabetes/Metabolism Research and Reviews 2013; 29(7): 515 doi: 10.1002/dmrr.2422
|
| 58 |
Chin‐Hsiao Tseng. Metformin and risk of hepatocellular carcinoma in patients with type 2 diabetes. Liver International 2018; 38(11): 2018 doi: 10.1111/liv.13872
|
| 59 |
Mina S Makary, Stuart Ramsell, Eric Miller, Eliza W Beal, Joshua D Dowell. Hepatocellular carcinoma locoregional therapies: Outcomes and future horizons. World Journal of Gastroenterology 2021; 27(43): 7462-7479 doi: 10.3748/wjg.v27.i43.7462
|
| 60 |
Jiachen Zheng, Ming Zhao, Jiahui Li, Guoying Lou, Yanyan Yuan, Shizhong Bu, Yang Xi. Obesity-associated digestive cancers: A review of mechanisms and interventions. Tumor Biology 2017; 39(3): 101042831769502 doi: 10.1177/1010428317695020
|
| 61 |
Mitsuru Ishizuka, Keiichi Kubota, Junji Kita, Mitsugi Shimoda, Masato Kato, Tokihiko Sawada. Survival after surgery for hepatocellular carcinoma in relation to presence or absence of viral infection. The American Journal of Surgery 2013; 206(2): 187 doi: 10.1016/j.amjsurg.2012.08.011
|
| 62 |
Aijun Li, Senlin Ma, Timothy Pawlik, Bin Wu, Xiaoyu Yang, Longjiu Cui, Mengchao Wu. Surgical treatment of double primary liver cancer. Medicine 2016; 95(32): e4412 doi: 10.1097/MD.0000000000004412
|
| 63 |
Melissa M. Center, Ahmedin Jemal. International Trends in Liver Cancer Incidence Rates. Cancer Epidemiology, Biomarkers & Prevention 2011; 20(11): 2362 doi: 10.1158/1055-9965.EPI-11-0643
|
| 64 |
Hisataka Fukushima, Hiroshi Kono, Kazuyoshi Hirayama, Yoshihiro Akazawa, Yuuki Nakata, Hiroyuki Wakana, Hideki Fujii. <p>Changes in Function and Dynamics in Hepatic and Splenic Macrophages in Non-Alcoholic Fatty Liver Disease</p>. Clinical and Experimental Gastroenterology 2020; : 305 doi: 10.2147/CEG.S248635
|
| 65 |
Anupam Bishayee. Inflammation and Cancer. Advances in Experimental Medicine and Biology 2014; 816: 401 doi: 10.1007/978-3-0348-0837-8_16
|
| 66 |
Takayuki Ozawa, Natsumi Maehara, Toshihiro Kai, Satoko Arai, Toru Miyazaki. Dietary fructose‐induced hepatocellular carcinoma development manifested in mice lacking apoptosis inhibitor of macrophage (AIM). Genes to Cells 2016; 21(12): 1320 doi: 10.1111/gtc.12446
|
| 67 |
Vincenzo De Francesco, Enzo Ierardi, Giuseppe Stoppino, Fabrizio Corsi, Maria Rosaria D’Agnessa, Michele Castriota, Cesare Hassan, Francesco Cianci, Angelo Zullo. Hepatic loss in a young patient: a very ‘cold case’. Internal and Emergency Medicine 2012; 7(1): 49 doi: 10.1007/s11739-011-0564-0
|
| 68 |
Nwe Ni Than, Anwar Ghazanfar, James Hodson, Nadeem Tehami, Chris Coldham, Hynek Mergental, Derek Manas, Tahir Shah, Philip N Newsome, Helen Reeves, Shishir Shetty. Comparing clinical presentations, treatments and outcomes of hepatocellular carcinoma due to hepatitis C and non-alcoholic fatty liver disease. QJM 2016; : hcw151 doi: 10.1093/qjmed/hcw151
|
| 69 |
Lei Wan. Materia Medica for Various Cancers. Evidence-based Anticancer Complementary and Alternative Medicine 2012; 2: 89 doi: 10.1007/978-94-007-1983-5_5
|
| 70 |
Vladimir Vartanian, Irina G. Minko, Supawadee Chawanthayatham, Patricia A. Egner, Ying-Chih Lin, Lauriel F. Earley, Rosemary Makar, Jennifer R. Eng, Matthew T. Camp, Liang Li, Michael P. Stone, Michael R. Lasarev, John D. Groopman, Robert G. Croy, John M. Essigmann, Amanda K. McCullough, R. Stephen Lloyd. NEIL1 protects against aflatoxin-induced hepatocellular carcinoma in mice. Proceedings of the National Academy of Sciences 2017; 114(16): 4207 doi: 10.1073/pnas.1620932114
|
| 71 |
Erdem Coskun, Pawel Jaruga, Vladimir Vartanian, Onur Erdem, Patricia A. Egner, John D. Groopman, R. Stephen Lloyd, Miral Dizdaroglu. Aflatoxin-Guanine DNA Adducts and Oxidatively Induced DNA Damage in Aflatoxin-Treated Mice in Vivo as Measured by Liquid Chromatography-Tandem Mass Spectrometry with Isotope Dilution. Chemical Research in Toxicology 2019; 32(1): 80 doi: 10.1021/acs.chemrestox.8b00202
|
| 72 |
Søren Friis, Ausrele Kesminiene, Carolina Espina, Anssi Auvinen, Kurt Straif, Joachim Schüz. European Code against Cancer 4th Edition: Medical exposures, including hormone therapy, and cancer. Cancer Epidemiology 2015; 39: S107 doi: 10.1016/j.canep.2015.08.003
|
| 73 |
Marcos António Gomes, Denise Gonçalves Priolli, José Guilherme Tralhão, Maria Filomena Botelho. Carcinoma hepatocelular: epidemiologia, biologia, diagnóstico e terapias. Revista da Associação Médica Brasileira 2013; 59(5): 514 doi: 10.1016/j.ramb.2013.03.005
|
| 74 |
Vivek Chavda, Kelsee K. Zajac, Jenna Lynn Gunn, Pankti Balar, Avinash Khadela, Dixa Vaghela, Shruti Soni, Charles R. Ashby, Amit K. Tiwari. Ethnic differences in hepatocellular carcinoma prevalence and therapeutic outcomes. Cancer Reports 2023; 6(S1) doi: 10.1002/cnr2.1821
|
| 75 |
Kathrina L. Marcelo, Anthony R. Means, Brian York. The Ca 2+ /Calmodulin/CaMKK2 Axis: Nature's Metabolic CaMshaft. Trends in Endocrinology & Metabolism 2016; 27(10): 706 doi: 10.1016/j.tem.2016.06.001
|
| 76 |
Hema Priya Manivannan, Vishnu Priya Veeraraghavan, Arul Prakash Francis. Prediction of Multi-targeting Pharmacological Activity of Bioactive Compounds from Medicinal Plants Against Hepatocellular Carcinoma Through Advanced Network Pharmacology and Bioinformatics-Based Investigation. Applied Biochemistry and Biotechnology 2025; doi: 10.1007/s12010-024-05150-8
|
| 77 |
Dandan Lin, Lei Lei, Yonghao Liu, Yinsheng Zhang, Bo Hu, Guangming Bao, Yuan Song, Ziqi Jin, Chunliang Liu, Yu Mei, Dedy Sandikin, Yan Wu, Lixiang Zhao, Xiao Yu, Haiyan Liu. Membrane IL1α Inhibits the Development of Hepatocellular Carcinoma via Promoting T- and NK-cell Activation. Cancer Research 2016; 76(11): 3179 doi: 10.1158/0008-5472.CAN-15-2658
|
| 78 |
Shih-Wei Lai, Pei-Chun Chen, Kuan-Fu Liao, Chih-Hsin Muo, Cheng-Chieh Lin, Fung-Chang Sung. Risk of Hepatocellular Carcinoma in Diabetic Patients and Risk Reduction Associated With Anti-Diabetic Therapy: A Population-Based Cohort Study. American Journal of Gastroenterology 2012; 107(1): 46 doi: 10.1038/ajg.2011.384
|
| 79 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 2931 doi: 10.1007/978-3-319-26956-6_164
|
| 80 |
Gehan Abd-Elfatah, Abdel-Naser Abdel-Atty Gad-Allah. RASSF1A, RECK genotypes and haplotypes in Egyptian population with Hepatocellular carcinoma. Immunology Letters 2016; 173: 36 doi: 10.1016/j.imlet.2016.02.013
|
| 81 |
Shivani Krishnamurthy, David Gilot, Seong Beom Ahn, Vincent Lam, Joo-Shik Shin, Gilles Jackie Guillemin, Benjamin Heng. Involvement of Kynurenine Pathway in Hepatocellular Carcinoma. Cancers 2021; 13(20): 5180 doi: 10.3390/cancers13205180
|
| 82 |
Anirban Kolay, Amitesh Kumar. A Novel Liver Cancer POC Diagnostic Detection Technique by a Gate-engineered Source-extended TFET Device. Medical Engineering & Physics 2024; 125: 104133 doi: 10.1016/j.medengphy.2024.104133
|
| 83 |
Yu Mei, Ying Zhu, Kylie Su Mei Yong, Zuhairah Binte Hanafi, Huanle Gong, Yonghao Liu, Huey Yee Teo, Muslima Hussain, Yuan Song, Qingfeng Chen, Haiyan Liu. IL-37 dampens immunosuppressive functions of MDSCs via metabolic reprogramming in the tumor microenvironment. Cell Reports 2024; 43(3): 113835 doi: 10.1016/j.celrep.2024.113835
|
| 84 |
Robert Vincent, Arun Sanyal. Recent Advances in Understanding of NASH: MicroRNAs as Both Biochemical Markers and Players. Current Pathobiology Reports 2014; 2(3): 109 doi: 10.1007/s40139-014-0049-8
|
| 85 |
Teng Li, Yun Liu, Yanming Sun. Long non-coding RNA AB209630 suppresses cell proliferation and metastasis in human hepatocellular carcinoma. Experimental and Therapeutic Medicine 2017; 14(4): 3419 doi: 10.3892/etm.2017.4927
|
| 86 |
Williams Puszyk, Keith Robertson, Chen Liu. Precision Molecular Pathology of Liver Cancer. Molecular Pathology Library 2018; : 69 doi: 10.1007/978-3-319-68082-8_5
|
| 87 |
Liang-Tzung Lin, Shu-Jing Wu, Chun-Ching Lin. The Anticancer Properties and Apoptosis-inducing Mechanisms of Cinnamaldehyde and the Herbal Prescription Huang-Lian-Jie-Du-Tang (黃連解毒湯 Huáng Lián Jiě Dú Tang) in Human Hepatoma Cells. Journal of Traditional and Complementary Medicine 2013; 3(4): 227 doi: 10.4103/2225-4110.119732
|
| 88 |
Chetram Deochand, Ming Tong, Amit R. Agarwal, Enrique Cadenas, Suzanne M. de la Monte. Tobacco Smoke Exposure Impairs Brain Insulin/IGF Signaling: Potential Co-Factor Role in Neurodegeneration. Journal of Alzheimer's Disease 2016; 50(2): 373 doi: 10.3233/JAD-150664
|
| 89 |
Michael Karin. New insights into the pathogenesis and treatment of non-viral hepatocellular carcinoma: a balancing act between immunosuppression and immunosurveillance. Precision Clinical Medicine 2018; 1(1): 21 doi: 10.1093/pcmedi/pby005
|
| 90 |
Fuminori Sonohara, Suguru Yamada, Nobutake Tanaka, Masaya Suenaga, Hideki Takami, Masamichi Hayashi, Yukiko Niwa, Hiroyuki Sugimoto, Norifumi Hattori, Mitsuro Kanda, Chie Tanaka, Daisuke Kobayashi, Goro Nakayama, Masahiko Koike, Michitaka Fujiwara, Yasuhiro Kodera. Perioperative and prognostic implication of albumin‐bilirubin‐TNM score in Child‐Pugh class A hepatocellular carcinoma. Annals of Gastroenterological Surgery 2019; 3(1): 65 doi: 10.1002/ags3.12212
|
| 91 |
Riccardo Inchingolo, Alessandro Posa, Martin Mariappan, Stavros Spiliopoulos. Locoregional treatments for hepatocellular carcinoma: Current evidence and future directions. World Journal of Gastroenterology 2019; 25(32): 4614-4628 doi: 10.3748/wjg.v25.i32.4614
|
| 92 |
Hamza Chettouh, Marie Lequoy, Laetitia Fartoux, Corinne Vigouroux, Christèle Desbois‐Mouthon. Hyperinsulinaemia and insulin signalling in the pathogenesis and the clinical course of hepatocellular carcinoma. Liver International 2015; 35(10): 2203 doi: 10.1111/liv.12903
|
| 93 |
Deniz Can Guven, Enes Erul, Taha Koray Sahin, Omer Dizdar, Suayib Yalcin, Ibrahim Halil Sahin. The Benefit of Immunotherapy in Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Future Oncology 2022; 18(37): 4119 doi: 10.2217/fon-2022-0642
|
| 94 |
Mariangela Garofalo, Federica Bellato, Salvatore Magliocca, Alessio Malfanti, Lukasz Kuryk, Beate Rinner, Samuele Negro, Stefano Salmaso, Paolo Caliceti, Francesca Mastrotto. Polymer Coated Oncolytic Adenovirus to Selectively Target Hepatocellular Carcinoma Cells. Pharmaceutics 2021; 13(7): 949 doi: 10.3390/pharmaceutics13070949
|
| 95 |
Maria Pipa-Muniz, Maria Varela, Luisa Gonzalez-Dieguez, Manuel Rodríguez. Personalized medicine in hepatocellular carcinoma: rationale and clinical data. Clinical Investigation 2011; 1(10): 1403 doi: 10.4155/cli.11.116
|
| 96 |
Melody Oncale, Brian Lewis. Hepatocellular Carcinoma with Extension to the Heart Via the Inferior Vena Cava. Baylor University Medical Center Proceedings 2015; 28(2): 229 doi: 10.1080/08998280.2015.11929240
|
| 97 |
Jianning Yao, Xuexiu Zhang, Jiaheng Li, Dongyao Zhao, Bing Gao, Haining Zhou, Shilin Gao, Lianfeng Zhang. Silencing TRIP13 inhibits cell growth and metastasis of hepatocellular carcinoma by activating of TGF-β1/smad3. Cancer Cell International 2018; 18(1) doi: 10.1186/s12935-018-0704-y
|
| 98 |
Xiao-Yan Duan, Lei Zhang, Jian-Gao Fan, Liang Qiao. NAFLD leads to liver cancer: Do we have sufficient evidence?. Cancer Letters 2014; 345(2): 230 doi: 10.1016/j.canlet.2013.07.033
|
| 99 |
Ginga Komatsu, Toru Nonomura, Mai Sasaki, Yuki Ishida, Satoko Arai, Toru Miyazaki. AIM-deficient mouse fed a high-trans fat, high-cholesterol diet: a new animal model for nonalcoholic fatty liver disease. Experimental Animals 2019; 68(2): 147 doi: 10.1538/expanim.18-0108
|
| 100 |
Kalyani Patil, Said Dermime, Shahab Uddin. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3. 2022; : 301 doi: 10.1016/B978-0-323-99283-1.00016-1
|
| 101 |
Alita Mishra, Munkhzul Otgonsuren, Chapy Venkatesan, Mariam Afendy, Madeline Erario, Zobair M. Younossi. The inpatient economic and mortality impact of hepatocellular carcinoma from 2005 to 2009: analysis of the US nationwide inpatient sample. Liver International 2013; 33(8): 1281 doi: 10.1111/liv.12201
|
| 102 |
Sara Guerra, Ana Catarina Mamede, Maria João Carvalho, Mafalda Laranjo, José Guilherme Tralhão, Ana Margarida Abrantes, Cláudio Jorge Maia, Maria Filomena Botelho. Liver diseases: what is known so far about the therapy with human amniotic membrane?. Cell and Tissue Banking 2016; 17(4): 653 doi: 10.1007/s10561-016-9579-0
|
| 103 |
Chi-Pang Wen, Jie Lin, Yi Chen Yang, Min Kuang Tsai, Chwen Keng Tsao, Carol Etzel, Maosheng Huang, Chung Yi Hsu, Yuanqing Ye, Lopa Mishra, Ernest Hawk, Xifeng Wu. Hepatocellular Carcinoma Risk Prediction Model for the General Population: The Predictive Power of Transaminases. JNCI: Journal of the National Cancer Institute 2012; 104(20): 1599 doi: 10.1093/jnci/djs372
|
| 104 |
Senem Senturk, Bulent Cetin, Mustafa Cengiz, Aslan Bilici, Selver Ozekinci. Dynamic multidetector computed tomography findings of hepatocellular carcinoma of hepatitis B virus-positive and -negative patients. Cancer Imaging 2014; 14(1) doi: 10.1186/1470-7330-14-9
|
| 105 |
Vishal Singh, Beng San Yeoh, Ahmed A. Abokor, Rachel M. Golonka, Yuan Tian, Andrew D. Patterson, Bina Joe, Mathias Heikenwalder, Matam Vijay-Kumar. Vancomycin prevents fermentable fiber-induced liver cancer in mice with dysbiotic gut microbiota. Gut Microbes 2020; 11(4): 1077 doi: 10.1080/19490976.2020.1743492
|
| 106 |
Kirti Shetty, Jian Chen, Ji-hyun Shin, Wilma Jogunoori, Lopa Mishra. Pathogenesis of Hepatocellular Carcinoma Development in Non-alcoholic Fatty Liver Disease. Current Hepatology Reports 2015; 14(2): 119 doi: 10.1007/s11901-015-0260-z
|
| 107 |
Olivier Rosmorduc, Laetitia Fartoux. Syndrome métabolique, stéatopathie hépatique non alcoolique (NASH) et carcinome hépatocellulaire : des liaisons bien dangereuses.... Bulletin de l'Académie Nationale de Médecine 2014; 198(9): 1653 doi: 10.1016/S0001-4079(19)31173-2
|
| 108 |
Xiao-Yan Duan, Qin Pan, Shi-Yan Yan, Wen-Jin Ding, Jian-Gao Fan, Liang Qiao. High-saturate-fat diet delays initiation of diethylnitrosamine-induced hepatocellular carcinoma. BMC Gastroenterology 2014; 14(1) doi: 10.1186/s12876-014-0195-9
|
| 109 |
Redha Al-Bahrani, Seishi Nagamori, Roger Leng, Anna Petryk, Consolato Sergi. Differential Expression of Sonic Hedgehog Protein in Human Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma. Pathology & Oncology Research 2015; 21(4): 901 doi: 10.1007/s12253-015-9918-7
|
| 110 |
Olga Pivovarova, Christian von Loeffelholz, Iryna Ilkavets, Carsten Sticht, Sergei Zhuk, Veronica Murahovschi, Sonja Lukowski, Stephanie Döcke, Jennifer Kriebel, Tonia de las Heras Gala, Anna Malashicheva, Anna Kostareva, Johan F Lock, Martin Stockmann, Harald Grallert, Norbert Gretz, Steven Dooley, Andreas FH Pfeiffer, Natalia Rudovich. Modulation of insulin degrading enzyme activity and liver cell proliferation. Cell Cycle 2015; 14(14): 2293 doi: 10.1080/15384101.2015.1046647
|
| 111 |
Hiromasa Ohira, Kazumichi Abe, Atsushi Takahashi, Mikio Zeniya, Takafumi Ichida. Clinical features of hepatocellular carcinoma in patients with autoimmune hepatitis in Japan. Journal of Gastroenterology 2013; 48(1): 109 doi: 10.1007/s00535-012-0616-x
|
| 112 |
Dengyang Fang, Zuming Xiong, Jinming Xu, Jun Yin, Runlan Luo. Chemopreventive mechanisms of galangin against hepatocellular carcinoma: A review. Biomedicine & Pharmacotherapy 2019; 109: 2054 doi: 10.1016/j.biopha.2018.09.154
|
| 113 |
Chao‐Tung Chen, Jing‐Yi Chen, Jing‐Houng Wang, Kuo‐Chin Chang, Po‐Lin Tseng, Kwong‐Ming Kee, Pao‐Fei Chen, Lin‐San Tsai, Shu‐Chuan Chen, Sheng‐Che Lin, Sheng‐Nan Lu. Diabetes mellitus, metabolic syndrome and obesity are not significant risk factors for hepatocellular carcinoma in an HBV‐ and HCV‐endemic area of Southern Taiwan. The Kaohsiung Journal of Medical Sciences 2013; 29(8): 451 doi: 10.1016/j.kjms.2012.12.006
|
| 114 |
Sanjit Boora, Vikrant Sharma, Sulochana Kaushik, Ajoy Varma Bhupatiraju, Sandeep Singh, Samander Kaushik. Hepatitis B virus-induced hepatocellular carcinoma: a persistent global problem. Brazilian Journal of Microbiology 2023; 54(2): 679 doi: 10.1007/s42770-023-00970-y
|
| 115 |
Toshihiro Kai, Tomoko Yamazaki, Satoko Arai, Toru Miyazaki, Marcia B. Aguila. Stabilization and Augmentation of Circulating AIM in Mice by Synthesized IgM-Fc. PLoS ONE 2014; 9(5): e97037 doi: 10.1371/journal.pone.0097037
|
| 116 |
Miranda S. Moore, Elena Ivanina, Katherine Bornschlegel, Baozhen Qiao, Maria J. Schymura, Fabienne Laraque. Hepatocellular Carcinoma and Viral Hepatitis in New York City. Clinical Infectious Diseases 2016; 63(12): 1577 doi: 10.1093/cid/ciw605
|
| 117 |
Edmondo Falleti, Carlo Fabris, Sara Cmet, Annarosa Cussigh, Davide Bitetto, Elisabetta Fontanini, Ezio Fornasiere, Sara Bignulin, Elisa Fumolo, Eleonora Bignulin, Mario Pirisi, Pierluigi Toniutto. PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence. Liver International 2011; 31(8): 1137 doi: 10.1111/j.1478-3231.2011.02534.x
|
| 118 |
Pierluigi Ramadori, Francisco Cubero, Christian Liedtke, Christian Trautwein, Yulia Nevzorova. Alcohol and Hepatocellular Carcinoma: Adding Fuel to the Flame. Cancers 2017; 9(10): 130 doi: 10.3390/cancers9100130
|
| 119 |
Renato Heidor, Ernesto Vargas-Mendez, Fernando Salvador Moreno. Epigenetics of Cancer Prevention. 2019; : 231 doi: 10.1016/B978-0-12-812494-9.00011-1
|
| 120 |
Aihua Zhang, Hui Sun, Xijun Wang. Mass Spectrometry‐Based Metabolomics in Clinical and Herbal Medicines. 2021; : 113 doi: 10.1002/9783527835751.ch8
|
| 121 |
Vadanasundari Vedarethinam, Karthik Dhanaraj, Soundharrajan Ilavenil, Mariadhas Arasu, Ki Choi, Naif Al-Dhabi, Srigopalram Srisesharam, Kyung Lee, Da Kim, Tamilvenvendan Dhanapal, Ravikumar Sivanesan, Han Choi, Young Kim. Antitumor Effect of the Mannich Base(1,3-bis-((3-Hydroxynaphthalen-2-yl)phenylmethyl)urea) on Hepatocellular Carcinoma. Molecules 2016; 21(5): 632 doi: 10.3390/molecules21050632
|